Viewing Study NCT02267603


Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2026-02-20 @ 6:05 PM
Study NCT ID: NCT02267603
Status: COMPLETED
Last Update Posted: 2023-07-05
First Post: 2014-10-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer
Sponsor:
Organization: